Purple Biotech logo

Purple Biotech Share Price (NASDAQ: PPBT)

$1.99

-0.28

(-12.33%)

Last updated on

Check the interactive Purple Biotech Stock chart to analyse performance

Purple Biotech stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$1.99
    Today's High:$2.20

    Day's Volatility :9.55%

  • 52 Weeks Low:$1.99
    52 Weeks High:$13.95

    52 Weeks Volatility :85.73%

Purple Biotech Stock Returns

PeriodPurple Biotech LtdIndex (Russel 2000)
3 Months
-25.37%
0.0%
6 Months
-29.08%
0.0%
1 Year
-79.04%
0.0%
3 Years
-95.63%
-4.7%

Purple Biotech Ltd Key Stats

Check Purple Biotech key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$2.27
Open
$2.2
Today's High
$2.2
Today's Low
$1.99
Market Capitalization
$6.1M
Today's Volume
$89.4K
52 Week High
$13.95
52 Week Low
$1.99
Revenue TTM
$0.0
EBITDA
$-5.8M
Earnings Per Share (EPS)
$-45.9
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-8.56%

Stock Returns calculator for Purple Biotech Stock including INR - Dollar returns

The Purple Biotech stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Purple Biotech investment value today

Current value as on today

₹25,632

Returns

₹74,368

(-74.37%)

Returns from Purple Biotech Stock

₹79,652 (-79.65%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Purple Biotech Stock

-15%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Purple Biotech Stock from India on INDmoney has decreased by -15% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Purple Biotech Ltd

  • Name

    Holdings %

  • UBS Group AG

    0.86%

  • Kingswood Wealth Advisors LLC

    0.63%

  • BNP Paribas Arbitrage, SA

    0.23%

  • Morgan Stanley - Brokerage Accounts

    0.17%

  • GAMMA Investing LLC

    0.17%

  • Rhumbline Advisers

    0.03%

Analyst Recommendation on Purple Biotech Stock

Rating
Trend

Purple Biotech Share Price Target

What analysts predicted

Upside of 1608.54%

Target:

$34.00

Current:

$1.99

Purple Biotech share price target is $34.00, a slight Upside of 1608.54% compared to current price of $1.99 as per analysts' prediction.

Purple Biotech Stock Insights

  • Price Movement

    In the last 7 days, PPBT stock has moved down by -12.9%
  • PPBT vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 149.5%
  • PPBT vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 208.2%

Purple Biotech Technicals Summary

Sell

Neutral

Buy

Purple Biotech is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Purple Biotech Ltd Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Purple Biotech Ltd logo
-7.83%
-29.08%
-79.04%
-95.63%
-97.62%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Purple Biotech Ltd

Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States. Its oncology pipeline includes CM24, a humanized monoclonal antibody that blocks the interactions of carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 2 clinical trial for the treatment of pancreatic ductal adenocarcinoma; NT219, a small molecule that targets and inhibits insulin receptor substrate 1 and 2, and signal transducer and activator of transcription, which is in Phase 1/2 clinical trials for the treatment recurrent and/or metastatic squamous cell carcinoma of the head and neck cancer or colorectal adenocarcinoma; and IM1240, a multi-valent antibody designed to activate anti-tumoral immune response against 5T4-positive tumors, which is in preclinical stage. The company has collaboration agreement with Bristol Myers Squibb Company to evaluate the combination of CM24 with the PD-1 inhibitor nivolumab in addition to chemotherapy. The company was formerly known as Kitov Pharma Ltd and changed its name to Purple Biotech Ltd. in December 2020. The company was incorporated in 1968 and is headquartered in Rehovot, Israel.
Organization
Purple Biotech
Employees
9
CEO
Mr. Gil Efron CPA, M.A.
Industry
Miscellaneous

Key Management of Purple Biotech Ltd

NameTitle
Mr. Gil Efron CPA, M.A.
Chief Executive Officer
Dr. Michael Schickler Ph.D.
Head of Clinical & Regulatory Affairs
Mr. Shai Lankry CPA, M.B.A.
Chief Financial Officer

Important FAQs about investing in PPBT Stock from India :

What is Purple Biotech share price today?

Purple Biotech share price today is $1.99 as on at the close of the market. Purple Biotech share today touched a day high of $2.20 and a low of $1.99.

What is the 52 week high and 52 week low for Purple Biotech share?

Purple Biotech share touched a 52 week high of $13.95 and a 52 week low of $1.99. Purple Biotech stock price today i.e. is closed at $1.99, lower by 85.73% versus the 52 week high.

How to invest in Purple Biotech Stock (PPBT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Purple Biotech on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Purple Biotech Shares that will get you 0.7538 shares as per Purple Biotech share price of $1.99 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Purple Biotech Stock (PPBT) from India?

Indian investors can start investing in Purple Biotech (PPBT) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Purple Biotech stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Purple Biotech share’s latest price of $1.99 as on August 30, 2025 at 1:29 am IST, you will get 5.0251 shares of Purple Biotech. Learn more about fractional shares .

What are the returns that Purple Biotech has given to Indian investors in the last 5 years?

Purple Biotech stock has given -97.62% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?